Team

Staff Profiles

Kyle Travaglini, Ph.D.

Scientist I

kyle.travaglini@alleninstitute.org

Kyle Travaglini is a Scientist at the Allen Institute for Brain Science. As a member of the Human Cell Types program, Kyle is focused on characterizing the molecular and cellular changes that underpin Alzheimer’s disease. Previously, he completed a Ph.D. in Biochemistry at Stanford University, where he constructed a single cell transcriptomic atlas of the human lung under the mentorship of Dr. Mark Krasnow. Prior to that, he conducted research with Dr. Steven Clark at the University of California, Los Angeles, where he received a B.S. in Biochemistry and identified a mechanism in yeast that helps ensure their proteins are built correctly.

Selected Publications

Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung

bioRxiv
May 10, 2022

Wu TTH, Travaglini KJ, Rustagi A, Xu D, Zhang Y, Jang SK, Gillich A, Dehghannasiri R, Martinez-Colon G, Beck A, Wilk AJ, Morri M, Trope WL, Shrager JB, Quake SR, Kuo CS, Salzman J, Kim PS, Blish CA, Krasnow MA

lveoli form directly by budding led by a single epithelial cell

bioRxiv
December 26, 2021

Gillich A, Julien KRS, Brownfield DG, Travaglini KJ, Metzger RJ, Krasnow MA

A molecular cell atlas of the human lung from single-cell RNA sequencing

Nature
July 15, 2020

The Tabula Muris Consortium

Capillary cell-type specialization in the alveolus

Nature
October 14, 2020

Gillich A, Zhang F, Farmer CG, Travaglini KJ, Tan SY, Gu M, Zhou B, Feinstein JA, Krasnow MA, Metzger RJ

0